Celcuity Closes $100 Million Private Placement Dec 12, 2022 07:30AM
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer Dec 7, 2022 04:00PM
Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update Aug 11, 2022 04:00PM
Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates May 16, 2022 04:00PM
Celcuity (CELC) Announces $100M Private Placement May 16, 2022 07:03AM


May 16, 2022 07:00AM Celcuity Inc. Announces $100 Million Private Placement